Longwen Xu
- Topics
- Ferroptosis and cancer prognosis (7 papers)Melanoma and MAPK Pathways (5 papers)Cutaneous Melanoma Detection and Management (5 papers)
- Cited by
- OncologyCancer ResearchImmunology
In The Last Decade
Longwen Xu
23 papers receiving 358 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 185
- Oncology 172
- Cancer Research 94
- Immunology 81
- Pulmonary and Respiratory Medicine 61
Countries citing papers authored by Longwen Xu
This map shows the geographic impact of Longwen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longwen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longwen Xu more than expected).
Fields of papers citing papers by Longwen Xu
This network shows the impact of papers produced by Longwen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longwen Xu. The network helps show where Longwen Xu may publish in the future.
Co-authorship network of co-authors of Longwen Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Longwen Xu. A scholar is included among the top collaborators of Longwen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longwen Xu. Longwen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 5 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 10 | |
| 7 | 13 | |
| 8 | 5 | |
| 9 | 8 | |
| 10 | 12 | |
| 11 | 5 | |
| 12 | 27 | |
| 13 | 7 | |
| 14 | 43 | |
| 15 | 3 | |
| 16 | 140 | |
| 17 | 9 | |
| 18 | 4 | |
| 19 | 19 | |
| 20 | 24 |
About Longwen Xu
Longwen Xu is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 361 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (7 papers), Melanoma and MAPK Pathways (5 papers) and Cutaneous Melanoma Detection and Management (5 papers). The work is most often cited by research in Oncology (172 citations), Cancer Research (94 citations) and Immunology (81 citations). Longwen Xu has collaborated with scholars based in China, Ethiopia and Taiwan. Frequent co-authors include Huan Yu, Jun Guo, Chuanliang Cui, Xiaowen Wu, Jie Dai, Tianxiao Xu, Junya Yan, Zhihong Chi, Yan Kong and Lu Si. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Immunology and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.